🇺🇸 RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F in United States

RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F (RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F in United States?

Marketing authorisation holder not available in our data.